There are three things that should be considered when deciding what is the optimal treatment in the first line setting for patients with chronic lymphocytic leukemia (CLL), according to Dr. Mazyar Shadman.
Mazyar Shadman
Advertisement
Articles by Mazyar Shadman
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
Diagnosed at 25 With Hodgkin's Lymphoma, She Says This Saved Her Life
2
Minimally Invasive Options in Rectal Cancer: TAMIS and Robotic Surgery
3
RASolute 302 and the Future of Pancreatic Cancer Treatment: Paul Oberstein, MD, on the KRAS Breakthrough
4
Why I Don’t Want to Hear “You’ll Beat This” After a Metastatic Breast Cancer Diagnosis
5